{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreidkqtrgwh652bns27tjuqky74uwrmwi2hzalaysetrzuhxpjrm74i",
    "uri": "at://did:plc:ox2kiwcr2xmn32p25g472pp7/app.bsky.feed.post/3mjd6q2faqsi2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreibh3gnjh6ojtbnabj2b7fvfgo3vsrtbqpnqdq3cazrvxtxva2f44q"
    },
    "mimeType": "image/webp",
    "size": 59126
  },
  "path": "/releases/2026/04/260411022029.htm",
  "publishedAt": "2026-04-12T08:58:54.000Z",
  "site": "https://www.sciencedaily.com",
  "textContent": "A new study reveals that popular diabetes and weight-loss drugs like Ozempic and Wegovy may not work as effectively for about 10% of people due to specific genetic variants. These individuals appear to have a puzzling condition called “GLP-1 resistance,” where their bodies produce higher levels of the hormone targeted by these drugs—but don’t respond to it properly.",
  "title": "Why Ozempic doesn’t work for everyone: Scientists just found a hidden reason"
}